Moreover, the interaction between calreticulin and toll-like receptor 4 (TLR4) expressed on tumor cell surface promotes the secretion of TNFα and CCL19, which facilitates the migration and maturation of DCs, to limit the tumor progression in vivo (49). The gene discussed is CALR; the disease is neoplasm.